Jason Satterfield, PhD
Implementation of evidence-based behavioral interventions in primary care including screening, brief interventions, and behaviorally-based treatments for tobacco and substance use disorders.
Suzaynn Schick, PhD
Effects of exposure to secondhand cigarette smoke on the upper and lower respiratory tract in human subjects and the chemical and physical changes that occur in aging secondhand smoke.
Laura Schmidt, PhD, MSW, MPH
Dr. Schmidt's central goal is to bridge the worlds of biomedical research, clinical practice and population health in ways that help us better understand some of the most pressing issues in health and health care today: the widening of health disparities and the societal of regulation risk factors in chronic disease. Substantive areas of her research include addiction, poverty, obesity-related metabolic disease—all burdens that are profoundly influenced by the organization of care and the social environment. A hallmark of her research is blended methodologies: she incorporates historical-archival, ethnographic and quantitative methods into most of her studies as a way to cross-validate findings and better interpret their meaning. Since its inception, her research program has been stably funded through awards from the National Institutes of Health (NIH) and US Substance Abuse and Mental Health Services Administration, in combination with funding from private foundations, including the Laura and John Arnold Foundation, Robert Wood Johnson Foundation (RWJF), Commonwealth Fund, Atlantic Philanthropies and Crossfit Foundation.
Steve Schroeder, MD
Determinants of medical expenditures, efficacy of medical cost containment, quality of care, and tobacco control with an emphasis on smoking cessation.
Mark Schumacher, MD, PhD
My goal is to leverage a better understanding of peripheral pain transduction to inspire more effective and non-addictive treatments for pain. In collaboration with the Hellman laboratory, we are investigating the role of TRPV1 and CB1 in sensory neurons as anti-inflammatory and analgesic targets for the minor cannabinoids.
Joel Simon, MD, MPH
Hospital-based and out-patient clinical trials of smoking cessation.
Elizabeth Smith, PhD
"Legitimate" tobacco industry activities, and tobacco industry relationships with other groups.
Joanne Spetz, PhD
Economics of the health care workforce, shortages and supply of registered nurses, organization and quality of the hospital industry, impact of health information technology, effect of medical marijuana policy on youth substance use, and the substance use disorder treatment workforce.
Matt Springer, PhD
Mechanisms underlying vascular reactivity and how they are affected by exposure to secondhand smoke from tobacco and marijuana.
Gideon St Helen, PhD
Utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.
Pages
Center Leadership
Pamela Ling, MD, MPH
Director, Center for Tobacco Control Research & Education
Dorie Apollonio, PhD, MPP
Fellowship Co-Director, Center for Tobacco Control Research & Education
Maya Vijayaraghavan, MD, MAS
Fellowship Co-Director, Center for Tobacco Control Research & Education
Research Spotlight
We have benchmarked opinions of a national sample of 16280 US adults on both the risks and benefits of marijuana use in 2017.
